stockrowIQVIA Holdings Inc.
IQV Healthcare Diagnostics & Research
IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.
- Revenue
- +8.00%
- EPS
- +10.2%
- Free cash flow
- −21.3%
- Total debt
- +7.42%
Quarter to September 2026, against a year earlier
Follow IQV
Alert me
IQVIA Holdings Inc. (IQV) Shares outstanding
IQVIA Holdings Inc.'s shares outstanding at the end of fiscal 2025 was $173.5M, down 5.40% from $183.4M in fiscal 2024. At the end of the quarter to 30 September 2026 it was $167.0M. Over the past ten years it has ranged from $125.6M (fiscal 2015) to $222.6M (fiscal 2017); the current reading is higher than 27% of that period. IQVIA Holdings Inc. ranks 9th of 49 Diagnostics & Research companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $173.5M | (5.40%) |
| FY2024 | $183.4M | (1.56%) |
| FY2023 | $186.3M | (2.26%) |
| FY2022 | $190.6M | (2.26%) |
| FY2021 | $195.0M | 0.00% |
| FY2020 | $195.0M | (2.30%) |
| FY2019 | $199.6M | (4.13%) |
| FY2018 | $208.2M | (6.47%) |
| FY2017 | $222.6M | 46.45% |
| FY2016 | $152.0M | 21.02% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $167.0M | (0.18%) |
| Jun 2026 | $167.3M | (1.47%) |
| Mar 2026 | $169.8M | (2.13%) |
| Dec 2025 | $173.5M | 1.05% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| A Agilent Technologies, Inc. compare | $283.0M |
| IQV IQVIA Holdings Inc. | $167.0M |
| ILMN Illumina, Inc. compare | $154.0M |
| NTRA Natera, Inc. compare | $144.1M |
| DGX Quest Diagnostics Incorporated compare | $112.0M |
| WAT Waters Corporation compare | $98.7M |
| LH Labcorp Holdings Inc. compare | $81.6M |
| IDXX IDEXX Laboratories, Inc. compare | $79.0M |
| MTD Mettler-Toledo International, Inc. compare | $20.2M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on IQV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement